Pharma Blog Watch

Targeted HIV Therapies (DrugWonks)
In his entry, Robert Goldberg discusses articles in various media outlets about the new HIV drugs in development, including Pfizer's maraviroc. "Left unsaid is that all these drugs are highly targeted with respect to the mutations of the HIV virus they either attack or block."

"In particular, Pfizer Inc.'s maraviroc will be launched in combination with a diagnostic called Trofile made by Monogram Biosciences," he writes. "Doctors and patients used the assay throughout the clinical development of maraviroc [to determine] a patient's likelihood for response and avoid side effects. If approved the combination will help determine if someone will benefit from the drug."